Literature DB >> 337651

Dengue viruses.

R W Schlesinger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 337651     DOI: 10.1007/978-3-7091-8466-0

Source DB:  PubMed          Journal:  Virol Monogr        ISSN: 0083-6591


× No keyword cloud information.
  10 in total

Review 1.  Dengue epidemiology and pathogenesis: images of the future viewed through a mirror of the past.

Authors:  Rashedul Islam; Mohammed Salahuddin; Md Salahuddin Ayubi; Tahmina Hossain; Apurba Majumder; Andrew W Taylor-Robinson; Abdullah Mahmud-Al-Rafat
Journal:  Virol Sin       Date:  2015-10-20       Impact factor: 4.327

2.  Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge.

Authors:  M Bray; R Men; C J Lai
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

3.  Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor.

Authors:  Susana Orozco; Michael A Schmid; Poornima Parameswaran; Ruben Lachica; Matthew R Henn; Robert Beatty; Eva Harris
Journal:  J Gen Virol       Date:  2012-07-18       Impact factor: 3.891

4.  Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.

Authors:  Y M Zhang; E P Hayes; T C McCarty; D R Dubois; P L Summers; K H Eckels; R M Chanock; C J Lai
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

5.  Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.

Authors:  A G Pletnev; M Bray; K A Hanley; J Speicher; R Elkins
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis.

Authors:  M Bray; B T Zhao; L Markoff; K H Eckels; R M Chanock; C J Lai
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

7.  The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers.

Authors:  Anna P Durbin; Peter F Wright; Amber Cox; Wangeci Kagucia; Daniel Elwood; Susan Henderson; Kimberli Wanionek; Jim Speicher; Stephen S Whitehead; Alexander G Pletnev
Journal:  Vaccine       Date:  2013-08-19       Impact factor: 3.641

8.  Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.

Authors:  Roland Züst; Ying-Xiu Toh; Iris Valdés; Daniela Cerny; Julia Heinrich; Lisset Hermida; Ernesto Marcos; Gerardo Guillén; Ulrich Kalinke; Pei-Yong Shi; Katja Fink
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

Review 9.  Animal models of dengue virus infection.

Authors:  Simona Zompi; Eva Harris
Journal:  Viruses       Date:  2012-01-09       Impact factor: 5.048

10.  Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.

Authors:  Ruklanthi de Alwis; Katherine L Williams; Michael A Schmid; Chih-Yun Lai; Bhumi Patel; Scott A Smith; James E Crowe; Wei-Kung Wang; Eva Harris; Aravinda M de Silva
Journal:  PLoS Pathog       Date:  2014-10-02       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.